טוען...
Targeted delivery of hyaluronic acid-coated solid lipid nanoparticles for rheumatoid arthritis therapy
Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disease. Long-term, high-dose glucocorticoid therapy can be used to treat the disease, but the fact that the drug distributes systemically can give rise to severe adverse effects. Here we develop a targeted system for treating RA in which...
שמור ב:
| הוצא לאור ב: | Drug Deliv |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6058688/ https://ncbi.nlm.nih.gov/pubmed/29516758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2018.1447050 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|